Candel Therapeutics, Inc. (CADL)

NASDAQ: CADL · Real-Time Price · USD

5.85

+0.22 (3.91%)

At close: Feb 18, 2026, 4:00 PM EST

5.73

-0.12 (-2.02%)

After-hours: Feb 18, 2026, 5:33 PM EST

Candel Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	86.96	102.65	35.41	70.06	82.64	35.05
Cash & Short-Term Investments	86.96	102.65	35.41	70.06	82.64	35.05
Cash Growth	425.20%	189.88%	-49.45%	-15.23%	135.76%	-22.20%
Prepaid Expenses	3.17	1.15	1.38	1.89	2.3	0.09
Total Current Assets	90.13	103.8	36.8	71.95	84.95	35.15
Property, Plant & Equipment	3.11	2.73	4.02	5.48	3.84	2.79
Other Long-Term Assets	0.35	0.33	0.38	0.27	0.42	0.35
Total Assets	93.6	106.87	41.2	77.69	89.21	38.28
Accounts Payable	1.12	0.24	0.42	0.38	1.59	0.92
Accrued Expenses	5.09	4.72	3.96	4.72	3.44	3.14
Short-Term Debt	-	-	-	-	-	0.46
Current Portion of Long-Term Debt	4.23	9.9	8.89	-	-	-
Current Portion of Leases	0.44	0.57	0.51	0.46	-	-
Other Current Liabilities	0.06	22.11	0.4	0.05	0.33	0.19
Total Current Liabilities	10.93	37.53	14.18	5.62	5.36	4.71
Long-Term Debt	0.97	2.6	12.38	20.85	0.56	0.48
Long-Term Leases	1.57	0.41	0.97	1.49	-	-
Long-Term Unearned Revenue	-	-	-	0.14	-	0.13
Other Long-Term Liabilities	-	-	0.92	1.88	19.15	7.46
Total Liabilities	13.47	40.54	28.46	29.98	25.07	12.78
Common Stock	0.55	0.47	0.29	0.29	0.29	0.12
Additional Paid-In Capital	280.91	258.51	149.93	146.96	144.15	20.49
Retained Earnings	-200.89	-192.21	-137.03	-99.09	-80.3	-44.17
Treasury Stock	-0.45	-0.45	-0.45	-0.45	-	-
Total Common Equity	80.12	66.33	12.75	47.71	64.14	-23.56
Shareholders' Equity	80.12	66.33	12.75	47.71	64.14	25.5
Total Liabilities & Equity	93.6	106.87	41.2	77.69	89.21	38.28
Total Debt	7.21	13.47	22.76	22.8	0.56	0.95
Net Cash (Debt)	79.76	89.18	12.65	47.26	82.08	34.11
Net Cash Growth	14807.66%	604.95%	-73.23%	-42.43%	140.66%	-23.59%
Net Cash Per Share	1.66	2.82	0.44	1.64	4.35	2.94
Filing Date Shares Outstanding	54.9	47.24	29.35	28.92	28.69	11.64
Total Common Shares Outstanding	54.9	46.81	29.09	28.92	28.69	11.64
Working Capital	79.21	66.28	22.61	66.33	79.58	30.43
Book Value Per Share	1.46	1.42	0.44	1.65	2.24	-2.03
Tangible Book Value	80.12	66.33	12.75	47.71	64.14	-23.56
Tangible Book Value Per Share	1.46	1.42	0.44	1.65	2.24	-2.03
Machinery	1.79	2.16	2.19	2.5	1.19	1.4
Construction In Progress	-	-	-	-	-	1.22
Leasehold Improvements	3	3.11	3.11	3.06	2.99	0.31

Updated Nov 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q